StockData
CVS HEALTH Corp logo

CVS HEALTH Corp

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)

Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%

Cvs Health Peer Benchmark by Year

Peer Benchmark — Centene Corporation (CNC, through Q3 2026): Total Revenues ($M)

Cvs Health Peer Benchmark: $194,777M in FY2025, up 19.4% from a year earlier. That is the highest of the 10 years on record here.

Latest, FY2025
194,777
Period ended Dec 31, 2025
Change on a year earlier
+19.4%
163,071 in FY2024
History
10 years
Since FY2016
Sources
1
Centene Corp. SEC 10-K (XBRL)

Where the FY2025 figure comes from

Source: Centene Corp. SEC 10-K (XBRL) ↗

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedPeer Benchmark — Centene Corporation (CNC, through Q3 2026): Total Revenues ($M)Year on yearSource
FY2025Dec 31, 2025194,777+19.4%Centene Corp. SEC 10-K (XBRL) ↗
FY2024Dec 31, 2024163,071+5.9%Centene Corp. SEC 10-K (XBRL) ↗
FY2023Dec 31, 2023153,999+6.5%Centene Corp. SEC 10-K (XBRL) ↗
FY2022Dec 31, 2022144,547+14.7%Centene Corp. SEC 10-K (XBRL) ↗
FY2021Dec 31, 2021125,982+13.4%Centene Corp. SEC 10-K (XBRL) ↗
FY2020Dec 31, 2020111,115+48.9%Centene Corp. SEC 10-K (XBRL) ↗
FY2019Dec 31, 201974,639+24.2%Centene Corp. SEC 10-K (XBRL) ↗
FY2018Dec 31, 201860,116+24.3%Centene Corp. SEC 10-K (XBRL) ↗
FY2017Dec 31, 201748,382+19.1%Centene Corp. SEC 10-K (XBRL) ↗
FY2016Dec 31, 201640,607–Centene Corp. SEC 10-K (XBRL) ↗

Breakdown

What makes up peer Benchmark

Cite this data

StockData. (2026). Cvs Health Peer Benchmark ($M), annual FY2016–FY2025 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/peer-cnc-revenue

See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.